About GlycosBio
GlycosBio is a private company based in Houston, Texas. It has reported $15,716,020 raised in seven offerings on Form D since April 2009.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 6, 2024 | Mar 21, 2024 | $1,125,000of $5.0M target | 5 | $225K | EquityRule 506(b) | Form D ↗ |
| Mar 30, 2023 | Apr 7, 2023 | $425,000of $1.0M target | 3 | $141K | EquityRule 506(b) | Form D ↗ |
| Sep 25, 2013 | Oct 11, 2013 | $375,250of $1.5M target | 3 | $125K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 15, 2013 | Feb 28, 2013 | $3,000,000of $5.0M target | 1 | $3.0M | Equity06 | Form D ↗ |
| Oct 8, 2010 | Oct 20, 2010 | $4,220,385of $12.0M target | 15 | $281K | Equity06 | Form D ↗ |
| Oct 8, 2010 | Oct 20, 2010 | $4,220,385of $12.0M target | 15 | $281K | Equity06 | Form D ↗ |
| Mar 24, 2009 | Apr 7, 2009 | $2,350,000of $3.2M target | 4 | $587K | Equity06 | Form D ↗ |
| Total, seven offerings | $15,716,020 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on GlycosBio's Form D filed Mar 21, 2024.
VN
Victoria Niklas
Director
JR
John Replogle
Director
RC
Richard Cilento
Executive officer and director
FF
Frank Foster
Director
JW
Joseph Walowski
Director
Earlier filings also listed Dan Watkins (director, last listed Apr 2023), Steve Jurvetson (director, last listed Jan 2017), Walter Burnap (president & chief financial officer, director, last listed Oct 2013), Gary Mossman (director, last listed Oct 2013) and Paul Campbell (executive officer and director, last listed Oct 2010).